Bicarbonate

Bicarbonate

SCHEMBL31492006

CCNN.O=C(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL55207 0.90 ALOX15 (0.59)
Acetic Acid SCHEMBL7132795 0.90 FFAR3 (0.47)
Acetic Acid SCHEMBL6449854 0.90 FFAR3 (0.47)
Acetic Acid SCHEMBL4492710 0.90
Acetic Acid SCHEMBL3891856 0.87
Succinic Acid SCHEMBL2126097 0.84 PHF8 (0.55)
Maleic Acid SCHEMBL28379898 0.82 TSHR (0.50)
SCHEMBL55546 0.80
Adipic Acid SCHEMBL7092451 0.80 AKR1B1 (0.59)
Acrylic Acid SCHEMBL17458929 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025046420-A1 COMPOUND TARGETING EGR-1 AND USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS 주식회사 아제라메디 2025-03-06 WO claimed
WO-2025046420-A1 COMPOUND TARGETING EGR-1 AND USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS 주식회사 아제라메디 2025-03-06 WO disclosed